Data set for "Taking aversive action: an experimental investigation into the negotiation of bodily limits."

Data set for "Taking aversive action: an experimental investigation into the negotiation of bodily limits."

This data set includes all data associated with the study, "Taking aversive action: an experimental investigation into the negotiation of bodily limits." The data include Gender, Age, BMI and Activity levels (IPAQ). In addition they include all data associated with the main variables of the study, including Interoceptive Accuracy, Heart Rate Variability, Anxiety Sensitivity, Porges Body awareness, and Mean Power Output. Absolute difference scores are provided for time intervals 1, 2, and 3.

Subjects:
Psychology

Cite this dataset as:
Tabor, A., 2019. Data set for "Taking aversive action: an experimental investigation into the negotiation of bodily limits.". University of Bath Research Data Archive. https://doi.org/10.15125/BATH-00516.

Export

Data

InterEx_Data_PLoS.sav
application/octet-stream (7kB)
Creative Commons: Attribution 4.0

Creators

Abby Tabor
University of Bath

Contributors

Chris Eccleston
Researcher
University of Bath

Niels Vollaard
Researcher
University of Stirling

Edmund Keogh
Researcher
University of Bath

University of Bath
Rights Holder

Documentation

Data collection method:

Thirty-eight participants (19F; Mean age: 23y; SD±4y) were recruited from a university campus through poster and electronic advertisement. All participants were screened for their health and activity level via the International Physical Activity Questionnaire (IPAQ short form) prior to the initiation of the study (Appendix. 1): only participants determined to be inactive (performed less than 3 x 20 minutes of vigorous exercise per week; <600 MET minutes) and otherwise healthy met the inclusion criteria (Total screened=40; two excluded due to activity levels). Participants were excluded if they had previously completed the maximal exercise tasks, were currently experiencing pain or had a history of pain lasting more than 3 months (full exclusion criteria: diagnosed cardiovascular disease, diagnosed respiratory disorder [COPD; cystic fibrosis] or neurological disorder [TIA, infarction/haemorrhage, cerebral palsy or neurological deficit], diagnosed psychiatric disorders [major depressive disorder; schizophrenia, bipolar]). This study was conducted in accordance with the declaration of Helsinki and ethical approval was obtained from divisions of Health and Psychology. All 38 participants provided written, informed consent. Participants were required to complete two separate sessions: first a baseline session and then a test session, with a minimum of 24 hours’ rest between each one. For the total duration of both sessions, participants wore a heart rate monitor, which was connected to a Polar V800 watch. All participants were asked to abstain from alcohol and caffeine in the preceding 24-hours of the baseline and test sessions.

Documentation Files

Coding%20Scheme_InteroEx.docx
application/vnd.openxmlformats-officedocument.wordprocessingml.document (19kB)
Creative Commons: Attribution 4.0

Funders

Reckitt Benckiser Healthcare

Bath Test of Attention to Pain

Publication details

Publication date: 22 March 2019
by: University of Bath

Version: 1

DOI: https://doi.org/10.15125/BATH-00516

URL for this record: https://researchdata.bath.ac.uk/id/eprint/516

Contact information

Please contact the Research Data Service in the first instance for all matters concerning this item.

Contact person: Abby Tabor

Departments:

Faculty of Humanities & Social Sciences
Health
Psychology